PARENTAL ORIGIN OF CHROMOSOME-22 LOSS IN SPORADIC AND NF2 NEUROMAS

被引:25
作者
FONTAINE, B
SANSON, M
DELATTRE, O
MENON, AG
ROULEAU, GA
SEIZINGER, BR
JEWELL, AF
HANSON, MP
AURIAS, A
MARTUZA, RL
GUSELLA, JF
THOMAS, G
机构
[1] INST CURIE, BIOL SECT, CNRS, URA 620, F-75231 PARIS 05, FRANCE
[2] MASSACHUSETTS GEN HOSP, MOLEC NEUROGENET LAB, BOSTON, MA 02129 USA
[3] MCGILL UNIV, MONTREAL GEN HOSP, RES INST, CTR RECH NEUROSCI, MONTREAL H3G 144, QUEBEC, CANADA
[4] MASSACHUSETTS GEN HOSP, BOSTON, MA 02114 USA
[5] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
关键词
D O I
10.1016/0888-7543(91)90513-E
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
It has recently been proposed that the maternally derived chromosome might be preferentially lost in nonfamilial cases of embryonal or early onset malignant tumors. This observation pointed to a potential role of the parental imprinting of the genome during gametogenesis which would be at least partly maintained in the somatic cells. Neuromas are benign tumors that develop from Schwann cells. They occur either sporadically or in individuals that have a genetic predisposition due to neurofibromatosis type 2 (NF2) and usually are multiple. Regardless of the context of occurrence, in approximately 40% of the investigated cases a loss of a chromosome 22 has been documented either by karyotype analysis or by monitoring somatic loss of heterozygosity. We have now examined the parental origin of the chromosome 22 lost in 19 cases of neuromas of patients with unaffected parents among which 11 were non-NF2 patients (sporadic and unique neuroma) and 8 were NF2 patients (bilateral acoustic or multiple neuromas). In both sets of tumors, the lost chromosome 22 can be of either parental origin. A close to threefold preference for the loss of the maternally derived chromosome was observed and should be either confirmed or disproved by studying a larger number of patients. © 1991.
引用
收藏
页码:280 / 283
页数:4
相关论文
共 32 条
  • [1] Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2
    Abaza, MM
    Makariou, E
    Armstrong, M
    Lalwani, AK
    [J]. LARYNGOSCOPE, 1996, 106 (06) : 694 - 699
  • [2] DIFFERENTIAL ACTIVITY OF MATERNALLY AND PATERNALLY DERIVED CHROMOSOME REGIONS IN MICE
    CATTANACH, BM
    KIRK, M
    [J]. NATURE, 1985, 315 (6019) : 496 - 498
  • [3] ASSESSMENT OF CHROMOSOME-22 ANOMALIES IN NEURINOMAS BY COMBINED KARYOTYPE AND RFLP ANALYSES
    COUTURIER, J
    DELATTRE, O
    KUJAS, M
    PHILIPPON, J
    PETER, M
    ROULEAU, G
    AURIAS, A
    THOMAS, G
    [J]. CANCER GENETICS AND CYTOGENETICS, 1990, 45 (01) : 55 - 62
  • [4] PARENTAL ORIGIN OF MUTATIONS OF THE RETINOBLASTOMA GENE
    DRYJA, TP
    MUKAI, S
    PETERSEN, R
    RAPAPORT, JM
    WALTON, D
    YANDELL, DW
    [J]. NATURE, 1989, 339 (6225) : 556 - 558
  • [5] A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY
    FEINBERG, AP
    VOGELSTEIN, B
    [J]. ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) : 6 - 13
  • [6] FONTAINE B, 1990, AM J HUM GENET, V47, P823
  • [7] FONTAINE B, 1990, IN PRESS ANN NY ACAD
  • [8] A POLYMORPHIC DNA MARKER GENETICALLY LINKED TO HUNTINGTONS-DISEASE
    GUSELLA, JF
    WEXLER, NS
    CONNEALLY, PM
    NAYLOR, SL
    ANDERSON, MA
    TANZI, RE
    WATKINS, PC
    OTTINA, K
    WALLACE, MR
    SAKAGUCHI, AY
    YOUNG, AB
    SHOULSON, I
    BONILLA, E
    MARTIN, JB
    [J]. NATURE, 1983, 306 (5940) : 234 - 238
  • [9] HALL JG, 1990, AM J HUM GENET, V46, P857
  • [10] POINT MUTATIONAL INACTIVATION OF THE RETINOBLASTOMA ANTIONCOGENE
    HOROWITZ, JM
    YANDELL, DW
    PARK, SH
    CANNING, S
    WHYTE, P
    BUCHKOVICH, K
    HARLOW, E
    WEINBERG, RA
    DRYJA, TP
    [J]. SCIENCE, 1989, 243 (4893) : 937 - 940